Literature DB >> 6134645

Trifluoperazine and other anaesthetics inhibit rat liver CTP: phosphocholine cytidylyltransferase.

S L Pelech, F Jetha, D E Vance.   

Abstract

Chlorpromazine (25 microM) and trifluoperazine (25 microM) inhibited by 5-fold the activity of CTP:phosphocholine cytidylyltransferase, the rate-limiting enzyme for phosphatidylcholine biosynthesis, in rat liver cytosol. Addition of saturating amounts of rat liver phospholipid to the enzyme assay rapidly reversed the drug-mediated inhibition. Three-fold or greater concentrations of these drugs were required to produce a 50% inhibition of the microsomal cytidylyltransferase. Incubation of rat hepatocytes with 20 microM trifluoperazine or chlorpromazine did not inhibit phosphatidylcholine biosynthesis. These results provide additional evidence for the hypothesis that the active form of cytidylyltransferase is on the endoplasmic reticulum and the enzyme in cytosol appears to be latent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134645     DOI: 10.1016/0014-5793(83)80682-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Opposing orientations of the anti-psychotic drug trifluoperazine selected by alternate conformations of M144 in calmodulin.

Authors:  Michael D Feldkamp; Lokesh Gakhar; Nisha Pandey; Madeline A Shea
Journal:  Proteins       Date:  2015-03-25

2.  Overweight induced by chronic risperidone exposure is correlated with overexpression of the SREBP-1c and FAS genes in mouse liver.

Authors:  Emilie Lauressergues; Françoise Martin; Audrey Helleboid; Emmanuel Bouchaert; Didier Cussac; Régis Bordet; Dean Hum; Gérald Luc; Zouher Majd; Bart Staels; Patrick Duriez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-19       Impact factor: 3.000

3.  Trifluoperazine increases fatty acid turnover in phospholipids in cultured human fibroblasts.

Authors:  C Mazière; J C Mazière; L Mora; M Auclair; J Polonovski
Journal:  Lipids       Date:  1988-05       Impact factor: 1.880

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.